
ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于实际控制人部分股份解除质押的公告 | 2018-05-14 | Chinese | |
| 关于公司股东减持计划时间过半未减持公司股份的进展公告 | 2018-05-09 | Chinese | |
| 关于控股股东开展融资融券业务的公告 | 2018-05-09 | Chinese | |
| 独立董事关于第三届董事会第四十三次会议相关事项的独立意见 | 2018-04-26 | Chinese | |
| 第三届监事会第三十一次会议决议公告 | 2018-04-26 | Chinese | |
| 2018年第一季度报告全文 | 2018-04-26 | Chinese |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 36028869 | 关于实际控制人部分股份解除质押的公告 | 2018-05-14 | Chinese | ||
| 36028856 | 关于公司股东减持计划时间过半未减持公司股份的进展公告 | 2018-05-09 | Chinese | ||
| 36028846 | 关于控股股东开展融资融券业务的公告 | 2018-05-09 | Chinese | ||
| 36028834 | 独立董事关于第三届董事会第四十三次会议相关事项的独立意见 | 2018-04-26 | Chinese | ||
| 36028824 | 第三届监事会第三十一次会议决议公告 | 2018-04-26 | Chinese | ||
| 36028806 | 2018年第一季度报告全文 | 2018-04-26 | Chinese | ||
| 36028786 | 2018年第一季度报告披露的提示性公告 | 2018-04-26 | Chinese | ||
| 36028771 | 关于注销部分已授予股票期权的公告 | 2018-04-26 | Chinese | ||
| 36028764 | 关于公司发行股份及支付现金购买资产暨关联交易事项获得中国证监会上市公司并购重组审核委员会审核通过暨公司股票复牌的公告 | 2018-04-26 | Chinese | ||
| 36028756 | 北京国枫律师事务所关于公司2017年股票期权激励计划之注销股票期权的法律意见书 | 2018-04-26 | Chinese | ||
| 36028746 | 第三届董事会第四十三次会议决议公告 | 2018-04-26 | Chinese | ||
| 36028739 | 关于中国证监会上市公司并购重组审核委员会审核公司发行股份及支付现金购买资产事项的停牌公告 | 2018-04-19 | Chinese | ||
| 36028730 | 发行股份及支付现金购买资产暨关联交易报告书 | 2018-04-13 | Chinese | ||
| 36028651 | 北京国枫律师事务所关于公司发行股份及支付现金购买资产暨关联交易的补充法律意见书之四 | 2018-04-13 | Chinese | ||
| 36028643 | 关于公司发行股份及支付现金购买资产暨关联交易之独立财务顾问报告 | 2018-04-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.